Otsuka America Pharmaceutical, Inc.
Lobbying group · Jul 2025 – Sep 2026
Otsuka America Pharmaceutical, Inc. spent $2.8M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, medicare & medicaid, taxes. It used 2 lobbyists.
- Spent on lobbying
- $2.8M
- Lobbyists
- 2
- Bills lobbied
- 6
- Issues
- 8
Spending by quarter
- 2025 Q3$340K
- 2025 Q4$1M
- 2026 Q1$210K
- 2026 Q2$1.2M
Issues lobbied
- Health care
- Medicare & Medicaid
- Taxes
- Veterans
- Budget & spending
- Tariffs
- Pharmacy
- Defense
Bills lobbied on
- H.R. 1: One Big Beautiful Bill Act2 reports
- S. 8322 reports
- H.R. 14922 reports
- H.R. 15182 reports
- S. 2903: Safe Step Act1 report
- H.R. 5509: Safe Step Act1 report
Lobbying firms hired
- Otsuka America Pharmaceutical, Inc.$2.8M
- W Strategies, LLC$200K
- Thorn Run Partners$200K
- Todd Strategy Group$200K
- DB3, LLC (Fka The Daschle Group)$160K
- Government Solutions LLC$30K
Agencies contacted
- House Of Representatives · 49
- Senate · 44
Related
Filings
- 2026 Q2 report$1.2M
- 2026 Q2 report$30K
- 2026 Q2 report$50K
- 2026 Q2 report$50K
- 2026 Q2 report$50K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Otsuka America Pharmaceutical, Inc.: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cotsukaamericapharmaceutical/otsuka-america-pharmaceutical-inc (accessed 2026-10-17).